Skip to Content
MilliporeSigma
All Photos(1)

Documents

PHR1324

Supelco

Meglumine

Pharmaceutical Secondary Standard; Certified Reference Material

Synonym(s):

N-Methyl-D-glucamine, 1-Deoxy-1-(methylamino)-D-glucitol, Meglumine

Sign Into View Organizational & Contract Pricing
All Photos(1)

About This Item

Empirical Formula (Hill Notation):
C7H17NO5
CAS Number:
6284-40-8
Molecular Weight:
195.21
Beilstein/REAXYS Number:
385906
EC Number:
228-506-9
MDL number:
MFCD00004707
UNSPSC Code:
41116107
PubChem Substance ID:
329823309
NACRES:
NA.24

grade

certified reference material
pharmaceutical secondary standard

Quality Level

300

agency

traceable to Ph. Eur. Y0001209
traceable to USP 1379140

API family

meglumine

CofA

current certificate can be downloaded

autoignition temp.

~662 °F

technique(s)

HPLC: suitable
gas chromatography (GC): suitable

mp

129-131.5 °C (lit.)

application(s)

pharmaceutical (small molecule)

format

neat

storage temp.

2-30°C

SMILES string

CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO

InChI

1S/C7H17NO5/c1-8-2-4(10)6(12)7(13)5(11)3-9/h4-13H,2-3H2,1H3/t4-,5+,6+,7+/m0/s1

InChI key

MBBZMMPHUWSWHV-BDVNFPICSA-N

Looking for similar products? Visit Product Comparison Guide

Related Categories

General description

Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
Meglumine is a glucose-derived secondary amine which is widely used as an excipient in pharmaceutical formulations.

Application

Meglumine may be used as a pharmaceutical reference standard for the determination of the analyte in pharmaceutical formulations by chromatography techniques.
These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.

Other Notes

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

Footnote

To see an example of a Certificate of Analysis for this material enter LRAC3472 in the slot below. This is an example certificate only and may not be the lot that you receive.

related product

Product No.
Description
Pricing

Storage Class

11 - Combustible Solids

wgk_germany

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
LRAD5986
LRAC3472
LRAA9118
LRAA0827

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Customers Also Viewed

Slide 1 of 1

1 of 1

Chloroquine phosphate Pharmaceutical Secondary Standard; Certified Reference Material

Supelco

PHR1258

Chloroquine phosphate

Simultaneous determination of positive and negative pharmaceutical counterions using mixed-mode chromatography coupled with charged aerosol detector
Zhang K, et al.
Journal of Chromatography A, 1217(37), 5776-5784 (2010)
Development and validation of a new HPLC-MS method for meglumine impurity profiling
Martano C, et al.
Journal of Pharmaceutical and Biomedical Analysis, 149(37), 517-524 (2018)
M Parant et al.
Ecotoxicology and environmental safety, 182, 109385-109385 (2019-07-02)
The present study was the first approach conducted under environmental concentrations of Gd-DOTA and Gd-DTPA-BMA to assess cellular impacts of these compounds. Gd-DOTA (Gadoteric acid) is one of the most stable contrast agent, currently used as Dotarem® formulation during Magnetic
Lourens F H J Robbers et al.
Radiology, 272(1), 113-122 (2014-03-13)
To investigate the effects of cell therapy on myocardial perfusion recovery after treatment of acute myocardial infarction (MI) with primary percutaneous coronary intervention (PCI). In this HEBE trial substudy, which was approved by the institutional review board (trial registry number
Hubert Cochet et al.
Radiology, 271(1), 239-247 (2014-01-31)
To demonstrate the feasibility of comprehensive assessment of cardiac arrhythmias by combining body surface electrocardiographic (ECG) mapping (BSM) and imaging. This study was approved by the institutional review board, and all patients gave written informed consent. Twenty-seven patients referred for
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service